{"product_id":"color-atlas-of-veterinary-ophthalmology-isbn-9781119239444","title":"Color Atlas of Veterinary Ophthalmology","description":"\u003ci\u003eColor Atlas of Veterinary Ophthalmology, Second Edition \u003c\/i\u003eprovides a compendium of the clinical appearance of ophthalmic diseases likely to be encountered in small, large, or exotic animal practice.  \u003cbr\u003e \u003cul\u003e \u003cli\u003eOffers a pictorial reference to the clinical appearance of diseases and conditions of the animal eye\u003c\/li\u003e \u003cli\u003ePresents multiple presentations of most ophthalmic diseases to show the varying ways the condition might appear\u003c\/li\u003e \u003cli\u003eProvides more than 1,000 high-quality color clinical photographs showing ocular disorders\u003c\/li\u003e \u003cli\u003eIncludes new introductory chapters on ocular anatomy, the ophthalmic exam, and clinical findings in place of the clinical signs chapter\u003c\/li\u003e \u003cli\u003eCovers clinical history, the clinical signs and findings associated with the disease, the rule-outs or differential diagnoses, the recommended treatment, and the prognosis for each disorder\u003c\/li\u003e \u003c\/ul\u003e \u003cp\u003ePreface xv\u003c\/p\u003e \u003cp\u003e\u003cb\u003e1 Ocular Anatomy 1\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 1.1 Eye anatomy 2\u003c\/p\u003e \u003cp\u003eFig. 1.2 Eyelid 5\u003c\/p\u003e \u003cp\u003e\u003cb\u003e2 The Ophthalmic Examination and Diagnostics 7\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 2.1 Ophthalmic examination equipment 8\u003c\/p\u003e \u003cp\u003eFig. 2.2 Ophthalmic examination 10\u003c\/p\u003e \u003cp\u003eFig. 2.3 Ophthalmic examination in a horse 11\u003c\/p\u003e \u003cp\u003eFig. 2.4 Nasolacrimal patency 12\u003c\/p\u003e \u003cp\u003eFig. 2.5 Microbiologic culture and susceptibility testing 13\u003c\/p\u003e \u003cp\u003eFig. 2.6 Cytology 14\u003c\/p\u003e \u003cp\u003eFig. 2.7 Ophthalmic stains 15\u003c\/p\u003e \u003cp\u003eFig. 2.8 Slit lamp biomicroscopy 17\u003c\/p\u003e \u003cp\u003eFig. 2.9 Intraocular pressure 18\u003c\/p\u003e \u003cp\u003eFig. 2.10 Gonioscopy 19\u003c\/p\u003e \u003cp\u003eFig. 2.11 Ophthalmoscopy 20\u003c\/p\u003e \u003cp\u003e\u003cb\u003e3 Clinical Signs and Their Interpretations 25\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 3.1 Blepharospasm 26\u003c\/p\u003e \u003cp\u003eFig. 3.2 Epiphora 27\u003c\/p\u003e \u003cp\u003eFig. 3.3 Exophthalmos\/enophthalmos\/strabismus 27\u003c\/p\u003e \u003cp\u003eFig. 3.4 Microphthalmia\/phthisis bulbus\/buphthalmos 29\u003c\/p\u003e \u003cp\u003eFig. 3.5 Conjunctival hyperemia 30\u003c\/p\u003e \u003cp\u003eFig. 3.6 Iridocyclitis 32\u003c\/p\u003e \u003cp\u003eFig. 3.7 Episcleral venous congestion 33\u003c\/p\u003e \u003cp\u003eFig. 3.8 Corneal edema 34\u003c\/p\u003e \u003cp\u003eFig. 3.9 Corneal ulceration\/vascularization 36\u003c\/p\u003e \u003cp\u003eFig. 3.10 Corneal pigmentation 38\u003c\/p\u003e \u003cp\u003eFig. 3.11 Corneal cellular infiltrate 38\u003c\/p\u003e \u003cp\u003eFig. 3.12 Sequestrum 40\u003c\/p\u003e \u003cp\u003eFig. 3.13 Corneal fibrosis 41\u003c\/p\u003e \u003cp\u003eFig. 3.14 Corneal lipidosis 42\u003c\/p\u003e \u003cp\u003eFig. 3.15 Hemorrhages 43\u003c\/p\u003e \u003cp\u003eFig. 3.16 Opacity in the anterior chamber 45\u003c\/p\u003e \u003cp\u003eFig. 3.17 Mydriasis\/miosis 46\u003c\/p\u003e \u003cp\u003eFig. 3.18 Posterior synechiae 47\u003c\/p\u003e \u003cp\u003eFig. 3.19 Rubeosis irides 48\u003c\/p\u003e \u003cp\u003eFig. 3.20 Acute chorioretinal inflammations 50\u003c\/p\u003e \u003cp\u003eFig. 3.21 Chronic chorioretinal inflammation 50\u003c\/p\u003e \u003cp\u003e\u003cb\u003e4 Canine Orbit 53\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 4.1 Microphthalmia 54\u003c\/p\u003e \u003cp\u003eFig. 4.2 Acute orbital cellulitis\/retrobulbar abscess 55\u003c\/p\u003e \u003cp\u003eFig. 4.3 Zygomatic salivary mucocele 56\u003c\/p\u003e \u003cp\u003eFig. 4.4 Acute masticatory myositis 57\u003c\/p\u003e \u003cp\u003eFig. 4.5 Bilateral polymyositis 58\u003c\/p\u003e \u003cp\u003eFig. 4.6 Microphthalmos\/strabismus 59\u003c\/p\u003e \u003cp\u003eFig. 4.7 Traumatic proptosis 60\u003c\/p\u003e \u003cp\u003eFig. 4.8 Orbital trauma 62\u003c\/p\u003e \u003cp\u003eFig. 4.9 Craniomandibular osteopathy 62\u003c\/p\u003e \u003cp\u003eFig. 4.10 Orbital masses 63\u003c\/p\u003e \u003cp\u003eFig. 4.11 Enucleation 64\u003c\/p\u003e \u003cp\u003eFig. 4.12 Intraocular silicone prosthesis 65\u003c\/p\u003e \u003cp\u003eFig. 4.13 Phthisis bulbus 66\u003c\/p\u003e \u003cp\u003e\u003cb\u003e5 Canine Eyelids 67\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 5.1 Ankyloblepharon 68\u003c\/p\u003e \u003cp\u003eFig. 5.2 Eyelid agenesis 68\u003c\/p\u003e \u003cp\u003eFig. 5.3 Dermoid 68\u003c\/p\u003e \u003cp\u003eFig. 5.4 Blepharophimosis 69\u003c\/p\u003e \u003cp\u003eFig. 5.5 Euryblepharon 69\u003c\/p\u003e \u003cp\u003eFig. 5.6 “V” notch in the central lower eyelid 70\u003c\/p\u003e \u003cp\u003eFig. 5.7 Entropion 71\u003c\/p\u003e \u003cp\u003eFig. 5.8 Ectropion 73\u003c\/p\u003e \u003cp\u003eFig. 5.9 Combined entropion–ectropion 74\u003c\/p\u003e \u003cp\u003eFig. 5.10 Distichia 75\u003c\/p\u003e \u003cp\u003eFig. 5.11 Ectopic cilia 76\u003c\/p\u003e \u003cp\u003eFig. 5.12 Trichomegaly 76\u003c\/p\u003e \u003cp\u003eFig. 5.13 Trichiasis 76\u003c\/p\u003e \u003cp\u003eFig. 5.14 Eyelid laceration 77\u003c\/p\u003e \u003cp\u003eFig. 5.15 Pyoderma blepharitis 78\u003c\/p\u003e \u003cp\u003eFig. 5.16 Sarcoptic mange 78\u003c\/p\u003e \u003cp\u003eFig. 5.17 Immune‐mediated blepharitis 79\u003c\/p\u003e \u003cp\u003eFig. 5.18 Pyogranulomatous blepharitis 79\u003c\/p\u003e \u003cp\u003eFig. 5.19 Uveodermatologic syndrome 80\u003c\/p\u003e \u003cp\u003eFig. 5.20 Meibomianitis 81\u003c\/p\u003e \u003cp\u003eFig. 5.21 Hordeolum\/chalazion 82\u003c\/p\u003e \u003cp\u003eFig. 5.22 Proliferative keratoconjunctivitis 82\u003c\/p\u003e \u003cp\u003eFig. 5.23 Adenoma of the meibomian gland 83\u003c\/p\u003e \u003cp\u003eFig. 5.24 Melanoma of the lower eyelid 84\u003c\/p\u003e \u003cp\u003eFig. 5.25 Squamous cell carcinoma\/mast cell tumor 84\u003c\/p\u003e \u003cp\u003eFig. 5.26 Histiocytoma 85\u003c\/p\u003e \u003cp\u003eFig. 5.27 Oral papillomatosis 85\u003c\/p\u003e \u003cp\u003e\u003cb\u003e6 Canine Tear and Nasolacrimal Systems 87\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 6.1 Acute keratoconjunctivitis sicca 88\u003c\/p\u003e \u003cp\u003eFig. 6.2 Chronic keratoconjunctivitis sicca 90\u003c\/p\u003e \u003cp\u003eFig. 6.3 Sequelae of acute keratoconjunctivitis sicca 91\u003c\/p\u003e \u003cp\u003eFig. 6.4 Qualitative keratoconjunctivitis sicca 92\u003c\/p\u003e \u003cp\u003eFig. 6.5 Entropion 93\u003c\/p\u003e \u003cp\u003eFig. 6.6 Acute dacryocystitis 93\u003c\/p\u003e \u003cp\u003eFig. 6.7 Longer term dacryocystitis 94\u003c\/p\u003e \u003cp\u003eFig. 6.8 Dacryocele\/dacryops 95\u003c\/p\u003e \u003cp\u003e\u003cb\u003e7 Canine Conjunctiva and Nictitating Membrane (Nictitans) 97\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 7.1 Encircling nictitans 98\u003c\/p\u003e \u003cp\u003eFig. 7.2 Dermoid of the lateral bulbar conjunctiva 98\u003c\/p\u003e \u003cp\u003eFig. 7.3 Everted cartilage 99\u003c\/p\u003e \u003cp\u003eFig. 7.4 Prolapse of nictitans tear glands 100\u003c\/p\u003e \u003cp\u003eFig. 7.5 Bilateral protrusion of the nictitans 101\u003c\/p\u003e \u003cp\u003eFig. 7.6 Plasma cell infiltration of the nictitans 101\u003c\/p\u003e \u003cp\u003eFig. 7.7 Foreign bodies in the nictitans 102\u003c\/p\u003e \u003cp\u003eFig. 7.8 Primary neoplasms of the nictitans 103\u003c\/p\u003e \u003cp\u003eFig. 7.9 Conjunctivitis 104\u003c\/p\u003e \u003cp\u003eFig. 7.10 Follicular conjunctivitis 105\u003c\/p\u003e \u003cp\u003eFig. 7.11 Chemosis of the conjunctiva 106\u003c\/p\u003e \u003cp\u003eFig. 7.12 Subconjunctival hemorrhage 107\u003c\/p\u003e \u003cp\u003eFig. 7.13 Non‐neoplastic inflammatory masses of the conjunctivas and nictitans 108\u003c\/p\u003e \u003cp\u003eFig. 7.14 Neoplasms of the canine conjunctiva 109\u003c\/p\u003e \u003cp\u003e\u003cb\u003e8 Canine Cornea and Sclera 111\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 8.1 Corneoconjunctival dermoid 112\u003c\/p\u003e \u003cp\u003eFig. 8.2 Ocular dysgenesis 112\u003c\/p\u003e \u003cp\u003eFig. 8.3 Persistent pupillary membranes 113\u003c\/p\u003e \u003cp\u003eFig. 8.4 Corneal erosion 114\u003c\/p\u003e \u003cp\u003eFig. 8.5 Corneal ulcer 115\u003c\/p\u003e \u003cp\u003eFig. 8.6 Central corneal ulcer 118\u003c\/p\u003e \u003cp\u003eFig. 8.7 Fungal keratitis 120\u003c\/p\u003e \u003cp\u003eFig. 8.8 Pigmentary keratitis 121\u003c\/p\u003e \u003cp\u003eFig. 8.9 Chronic superficial keratitis 122\u003c\/p\u003e \u003cp\u003eFig. 8.10 Neuroparalytic keratitis 124\u003c\/p\u003e \u003cp\u003eFig. 8.11 Neurotropic keratitis 125\u003c\/p\u003e \u003cp\u003eFig. 8.12 Keratitis 125\u003c\/p\u003e \u003cp\u003eFig. 8.13 Florida keratopathy 128\u003c\/p\u003e \u003cp\u003eFig. 8.14 Corneal laceration 128\u003c\/p\u003e \u003cp\u003eFig. 8.15 Corneal foreign bodies 130\u003c\/p\u003e \u003cp\u003eFig. 8.16 Corneal stromal dystrophies 132\u003c\/p\u003e \u003cp\u003eFig. 8.17 Endothelial corneal dystrophy 133\u003c\/p\u003e \u003cp\u003eFig. 8.18 Corneal degeneration 135\u003c\/p\u003e \u003cp\u003eFig. 8.19 Corneal cyst 137\u003c\/p\u003e \u003cp\u003eFig. 8.20 Limbal melanoma 138\u003c\/p\u003e \u003cp\u003eFig. 8.21 Scleral and conjunctival icterus 138\u003c\/p\u003e \u003cp\u003eFig. 8.22 Staphyloma 139\u003c\/p\u003e \u003cp\u003eFig. 8.23 Proliferative keratoconjunctivitis 139\u003c\/p\u003e \u003cp\u003e\u003cb\u003e9 Canine Glaucomas 143\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 9.1 Optic nerve head and primary open angle glaucoma 144\u003c\/p\u003e \u003cp\u003eFig. 9.2 Optic nerve head changes in primary narrow\/closed angle glaucoma 144\u003c\/p\u003e \u003cp\u003eFig. 9.3 Congenital glaucoma 145\u003c\/p\u003e \u003cp\u003eFig. 9.4 Congenital glaucoma 145\u003c\/p\u003e \u003cp\u003eFig. 9.5 Primary narrow\/closed angle glaucoma 146\u003c\/p\u003e \u003cp\u003eFig. 9.6 Primary narrow\/closed angle glaucoma with pectinate ligament dysplasia 148\u003c\/p\u003e \u003cp\u003eFig. 9.7 Primary narrow\/closed angle glaucoma and globe enlargement 150\u003c\/p\u003e \u003cp\u003eFig. 9.8 Lens luxations or displacements 151\u003c\/p\u003e \u003cp\u003eFig. 9.9 Cataract formation, resorption, lens‐induced uveitis, and glaucoma 153\u003c\/p\u003e \u003cp\u003eFig. 9.10 Chronic uveitis\/uveal cysts syndrome 155\u003c\/p\u003e \u003cp\u003eFig. 9.11 Secondary aphakic\/pseudophakic glaucoma 157\u003c\/p\u003e \u003cp\u003eFig. 9.12 Traumatic glaucoma 157\u003c\/p\u003e \u003cp\u003eFig. 9.13 Secondary glaucoma from intraocular hemorrhage 158\u003c\/p\u003e \u003cp\u003eFig. 9.14 Pigmentary glaucoma 158\u003c\/p\u003e \u003cp\u003eFig. 9.15 Secondary glaucoma and malignant melanoma of the ciliary body 159\u003c\/p\u003e \u003cp\u003eFig. 9.16 Secondary glaucoma and ciliary body primary adenocarcinoma 159\u003c\/p\u003e \u003cp\u003eFig. 9.17 Secondary glaucoma and metastatic nasal adenocarcinoma 160\u003c\/p\u003e \u003cp\u003eFig. 9.18 Glaucoma secondary to anterior uveitis and lymphoma 160\u003c\/p\u003e \u003cp\u003eFig. 9.19 Glaucoma secondary to anterior uveitis and lymphoma 160\u003c\/p\u003e \u003cp\u003eFig. 9.20 Surgical and laser treatment for canine glaucoma 161\u003c\/p\u003e \u003cp\u003e\u003cb\u003e10 Canine Anterior Uvea 163\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 10.1 Heterochromia iridis 164\u003c\/p\u003e \u003cp\u003eFig. 10.2 Merle ocular dysgenesis 165\u003c\/p\u003e \u003cp\u003eFig. 10.3 Persistent pupillary membranes 166\u003c\/p\u003e \u003cp\u003eFig. 10.4 Iridal nests 167\u003c\/p\u003e \u003cp\u003eFig. 10.5 Iridal coloboma 167\u003c\/p\u003e \u003cp\u003eFig. 10.6 Acute iridocyclitis 168\u003c\/p\u003e \u003cp\u003eFig. 10.7 Uveodermatologic syndrome\/chronic anterior uveitis 170\u003c\/p\u003e \u003cp\u003eFig. 10.8 Anterior uveitis following rickettsial infestation 171\u003c\/p\u003e \u003cp\u003eFig. 10.9 Iridocyclitis following heartworm infestation 171\u003c\/p\u003e \u003cp\u003eFig. 10.10 Anterior uveitis secondary to infectious canine hepatitis 172\u003c\/p\u003e \u003cp\u003eFig. 10.11 Mycotic iridocyclitis and chorioretinitis 173\u003c\/p\u003e \u003cp\u003eFig. 10.12 Iridocyclitis and cataract 174\u003c\/p\u003e \u003cp\u003eFig. 10.13 Pigmentary uveitis 175\u003c\/p\u003e \u003cp\u003eFig. 10.14 Uveodermatologic syndrome 176\u003c\/p\u003e \u003cp\u003eFig. 10.15 Senile iris atrophy 178\u003c\/p\u003e \u003cp\u003eFig. 10.16 Anterior uveal trauma 179\u003c\/p\u003e \u003cp\u003eFig. 10.17 Hyphema 180\u003c\/p\u003e \u003cp\u003eFig. 10.18 Melanoma 182\u003c\/p\u003e \u003cp\u003eFig. 10.19 Ciliary body adenoma\/adenocarcinoma 184\u003c\/p\u003e \u003cp\u003eFig. 10.20 Metastatic adenocarcinoma of the ciliary body 185\u003c\/p\u003e \u003cp\u003eFig. 10.21 Lymphoma 185\u003c\/p\u003e \u003cp\u003e\u003cb\u003e11 Canine Lens and Cataract Formation 187\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 11.1 Microphakia 188\u003c\/p\u003e \u003cp\u003eFig. 11.2 Lens coloboma 188\u003c\/p\u003e \u003cp\u003eFig. 11.3 Lenticonus 188\u003c\/p\u003e \u003cp\u003eFig. 11.4 Persistent pupillary membranes leading to cataract 189\u003c\/p\u003e \u003cp\u003eFig. 11.5 Persistent hyaloid and posterior cataracts 190\u003c\/p\u003e \u003cp\u003eFig. 11.6 Cataract formation 191\u003c\/p\u003e \u003cp\u003eFig. 11.7 Nuclear sclerosis of the lens 192\u003c\/p\u003e \u003cp\u003eFig. 11.8 Cataract formation classified by stage of maturity 193\u003c\/p\u003e \u003cp\u003eFig. 11.9 Age of onset and area(s) or region of the lens first involved in cataract formation 196\u003c\/p\u003e \u003cp\u003eFig. 11.10 Diabetic cataract 199\u003c\/p\u003e \u003cp\u003eFig. 11.11 Cataract secondary to inflammation 200\u003c\/p\u003e \u003cp\u003eFig. 11.12 Lens injury following penetrating or blunt trauma 201\u003c\/p\u003e \u003cp\u003eFig. 11.13 Resorbing hypermature cataract 201\u003c\/p\u003e \u003cp\u003eFig. 11.14 Lens subluxation 204\u003c\/p\u003e \u003cp\u003eFig. 11.15 Anterior lens luxation 205\u003c\/p\u003e \u003cp\u003eFig. 11.16 Posterior lens luxation 206\u003c\/p\u003e \u003cp\u003eFig. 11.17 Intraocular lens placement after lens extraction 207\u003c\/p\u003e \u003cp\u003e\u003cb\u003e12 Canine Vitreous 209\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 12.1 Hyaloid remnants 210\u003c\/p\u003e \u003cp\u003eFig. 12.2 Persistent hyperplastic tunica vasculosa lentis 210\u003c\/p\u003e \u003cp\u003eFig. 12.3 Asteroid hyalosis 211\u003c\/p\u003e \u003cp\u003eFig. 12.4 Vitritis following infection 213\u003c\/p\u003e \u003cp\u003eFig. 12.5 Vitreal hemorrhage 214\u003c\/p\u003e \u003cp\u003e\u003cb\u003e13 Canine Ocular Fundus and Optic Nerve 215\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 13.1 Normal variations of the ocular fundus and optic nerve head or disc 216\u003c\/p\u003e \u003cp\u003eFig. 13.2 Collie eye anomaly 217\u003c\/p\u003e \u003cp\u003eFig. 13.3 Retinal dysplasia 219\u003c\/p\u003e \u003cp\u003eFig. 13.4 Progressive retinal atrophy 221\u003c\/p\u003e \u003cp\u003eFig. 13.5 Retinal pigment epithelium dystrophy 223\u003c\/p\u003e \u003cp\u003eFig. 13.6 Inflammations of the retina and choroid 224\u003c\/p\u003e \u003cp\u003eFig. 13.7 Sudden acquired retinal degeneration 225\u003c\/p\u003e \u003cp\u003eFig. 13.8 Ophthalmic manifestations of systemic hypertension 226\u003c\/p\u003e \u003cp\u003eFig. 13.9 Lipemia retinalis 227\u003c\/p\u003e \u003cp\u003eFig. 13.10 Hyperviscosity syndrome 227\u003c\/p\u003e \u003cp\u003eFig. 13.11 Retinal detachment 229\u003c\/p\u003e \u003cp\u003eFig. 13.12 Granulomatous meningoencephalitis 230\u003c\/p\u003e \u003cp\u003eFig. 13.13 Neoplasms of the ocular fundus 231\u003c\/p\u003e \u003cp\u003eFig. 13.14 Optic nerve head disease 231\u003c\/p\u003e \u003cp\u003eFig. 13.15 Micropapilla 232\u003c\/p\u003e \u003cp\u003eFig. 13.16 Optic nerve hypoplasia 232\u003c\/p\u003e \u003cp\u003eFig. 13.17 Optic nerve coloboma 233\u003c\/p\u003e \u003cp\u003eFig. 13.18 Papilledema associated with orbital neoplasm 234\u003c\/p\u003e \u003cp\u003eFig. 13.19 Optic neuritis 234\u003c\/p\u003e \u003cp\u003eFig. 13.20 Optic nerve atrophy 235\u003c\/p\u003e \u003cp\u003e\u003cb\u003e14 Feline Ophthalmology 237\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 14.1 Microphthalmia\/symblepharon 238\u003c\/p\u003e \u003cp\u003eFig. 14.2 Proptosis 238\u003c\/p\u003e \u003cp\u003eFig. 14.3 Orbital cellulitis 239\u003c\/p\u003e \u003cp\u003eFig. 14.4 Orbital neoplasms 240\u003c\/p\u003e \u003cp\u003eFig. 14.5 Eyelid agenesis 241\u003c\/p\u003e \u003cp\u003eFig. 14.6 Entropion 243\u003c\/p\u003e \u003cp\u003eFig. 14.7 Blepharitis 243\u003c\/p\u003e \u003cp\u003eFig. 14.8 Eyelid neoplasia 244\u003c\/p\u003e \u003cp\u003eFig. 14.9 Keratoconjunctivitis sicca 246\u003c\/p\u003e \u003cp\u003eFig. 14.10 Ophthalmic manifestations of feline herpesvirus‐1 247\u003c\/p\u003e \u003cp\u003eFig. 14.11 Recurrent feline herpesvirus‐1 conjunctivitis 248\u003c\/p\u003e \u003cp\u003eFig. 14.12 \u003ci\u003eChlamydia \u003c\/i\u003econjunctivitis 248\u003c\/p\u003e \u003cp\u003eFig. 14.13 Mycoplasmal conjunctivitis 249\u003c\/p\u003e \u003cp\u003eFig. 14.14 Symblepharon 250\u003c\/p\u003e \u003cp\u003eFig. 14.15 Lipogranulomatous conjunctivitis 250\u003c\/p\u003e \u003cp\u003eFig. 14.16 Corneal ulceration following feline herpesvirus‐1 infection 251\u003c\/p\u003e \u003cp\u003eFig. 14.17 Feline herpesvirus‐1 stromal keratitis 252\u003c\/p\u003e \u003cp\u003eFig. 14.18 Corneal sequestration and corneal ulceration 252\u003c\/p\u003e \u003cp\u003eFig. 14.19 Eosinophilic keratoconjunctivitis 254\u003c\/p\u003e \u003cp\u003eFig. 14.20 Florida keratopathy 255\u003c\/p\u003e \u003cp\u003eFig. 14.21 Bullous keratopathy 255\u003c\/p\u003e \u003cp\u003eFig. 14.22 Limbal melanoma\/conjunctival lymphoma 256\u003c\/p\u003e \u003cp\u003eFig. 14.23 Heterochromia iridis 256\u003c\/p\u003e \u003cp\u003eFig. 14.24 Persistent pupillary membranes 257\u003c\/p\u003e \u003cp\u003eFig. 14.25 Iridocyclitis or anterior uveitis 258\u003c\/p\u003e \u003cp\u003eFig. 14.26 Anterior uveitis in a cat with infectious peritonitis 259\u003c\/p\u003e \u003cp\u003eFig. 14.27 Anterior uveitis in a cat with feline leukemia 260\u003c\/p\u003e \u003cp\u003eFig. 14.28 Panuveitis caused by feline immunodeficiency virus 261\u003c\/p\u003e \u003cp\u003eFig. 14.29 Chronic panuveitis caused by toxoplasmosis 262\u003c\/p\u003e \u003cp\u003eFig. 14.30 Ophthalmic trauma 263\u003c\/p\u003e \u003cp\u003eFig. 14.31 Diffuse iridal melanoma 264\u003c\/p\u003e \u003cp\u003eFig. 14.32 Anterior uveal melanomas 266\u003c\/p\u003e \u003cp\u003eFig. 14.33 Ciliary body adenocarcinoma 267\u003c\/p\u003e \u003cp\u003eFig. 14.34 Trauma‐associated sarcoma 268\u003c\/p\u003e \u003cp\u003eFig. 14.35 Ophthalmic manifestations of systemic lymphoma 268\u003c\/p\u003e \u003cp\u003eFig. 14.36 Bilateral congenital glaucoma 269\u003c\/p\u003e \u003cp\u003eFig. 14.37 Ophthalmic manifestations of primary glaucomas 270\u003c\/p\u003e \u003cp\u003eFig. 14.38 Aqueous misdirection 271\u003c\/p\u003e \u003cp\u003eFig. 14.39 Anterior lens luxation 272\u003c\/p\u003e \u003cp\u003eFig. 14.40 Cataracts 273\u003c\/p\u003e \u003cp\u003eFig. 14.41 Primary cataracts 274\u003c\/p\u003e \u003cp\u003eFig. 14.42 Secondary cataracts 275\u003c\/p\u003e \u003cp\u003eFig. 14.43 Normal feline ocular fundus 276\u003c\/p\u003e \u003cp\u003eFig. 14.44 Retinal dysplasia 277\u003c\/p\u003e \u003cp\u003eFig. 14.45 Taurine retinopathy 277\u003c\/p\u003e \u003cp\u003eFig. 14.46 Rod–cone dysplasia\/rod–cone dystrophy 278\u003c\/p\u003e \u003cp\u003eFig. 14.47 Chorioretinitis 278\u003c\/p\u003e \u003cp\u003eFig. 14.48 Chorioretinitis secondary to cryptococcosis 280\u003c\/p\u003e \u003cp\u003eFig. 14.49 Hypertensive retinopathy 281\u003c\/p\u003e \u003cp\u003eFig. 14.50 Retinal degeneration 282\u003c\/p\u003e \u003cp\u003eFig. 14.51 Ocular ophthalmomyiasis 283\u003c\/p\u003e \u003cp\u003eFig. 14.52 Retinal detachments 284\u003c\/p\u003e \u003cp\u003e\u003cb\u003e15 Equine Ophthalmology 285\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 15.1 Microphthalmia 286\u003c\/p\u003e \u003cp\u003eFig. 15.2 Strabismus 286\u003c\/p\u003e \u003cp\u003eFig. 15.3 Entropion 286\u003c\/p\u003e \u003cp\u003eFig. 15.4 Pigmented dermoid 287\u003c\/p\u003e \u003cp\u003eFig. 15.5 Nasolacrimal duct atresia 288\u003c\/p\u003e \u003cp\u003eFig. 15.6 Heterochromia iridis\/iris hypoplasia 289\u003c\/p\u003e \u003cp\u003eFig. 15.7 Congenital glaucoma and lens subluxation 290\u003c\/p\u003e \u003cp\u003eFig. 15.8 Iridocyclitis 290\u003c\/p\u003e \u003cp\u003eFig. 15.9 Congenital cataract 291\u003c\/p\u003e \u003cp\u003eFig. 15.10 Optic nerve hypoplasia 292\u003c\/p\u003e \u003cp\u003eFig. 15.11 Orbit cellulitis 292\u003c\/p\u003e \u003cp\u003eFig. 15.12 Orbital trauma 293\u003c\/p\u003e \u003cp\u003eFig. 15.13 Orbital tumors 294\u003c\/p\u003e \u003cp\u003eFig. 15.14 Phthisis bulbus 295\u003c\/p\u003e \u003cp\u003eFig. 15.15 Eyelid laceration 295\u003c\/p\u003e \u003cp\u003eFig. 15.16 Squamous cell carcinoma 295\u003c\/p\u003e \u003cp\u003eFig. 15.17 Sarcoid 297\u003c\/p\u003e \u003cp\u003eFig. 15.18 Melanoma 298\u003c\/p\u003e \u003cp\u003eFig. 15.19 Corpora nigra cyst 299\u003c\/p\u003e \u003cp\u003eFig. 15.20 Duct obstruction 300\u003c\/p\u003e \u003cp\u003eFig. 15.21 Dacryocystitis and secondary conjunctivitis 300\u003c\/p\u003e \u003cp\u003eFig. 15.22 Habronemiasis 301\u003c\/p\u003e \u003cp\u003eFig. 15.23 Corneal ulceration 301\u003c\/p\u003e \u003cp\u003eFig. 15.24 Corneal stromal abscess 305\u003c\/p\u003e \u003cp\u003eFig. 15.25 Herpes viral keratitis 306\u003c\/p\u003e \u003cp\u003eFig. 15.26 Corneal lacerations 306\u003c\/p\u003e \u003cp\u003eFig. 15.27 Eosinophilic keratitis 307\u003c\/p\u003e \u003cp\u003eFig. 15.28 Traumatic hyphema 308\u003c\/p\u003e \u003cp\u003eFig. 15.29 Acute equine recurrent uveitis 309\u003c\/p\u003e \u003cp\u003eFig. 15.30 Chronic equine recurrent uveitis 309\u003c\/p\u003e \u003cp\u003eFig. 15.31 Chronic equine recurrent uveitis and secondary cataract 310\u003c\/p\u003e \u003cp\u003eFig. 15.32 Glaucoma 310\u003c\/p\u003e \u003cp\u003eFig. 15.33 Acquired cataracts 311\u003c\/p\u003e \u003cp\u003eFig. 15.34 Lens subluxation 312\u003c\/p\u003e \u003cp\u003eFig. 15.35 Treatment after phacoemulsification 313\u003c\/p\u003e \u003cp\u003eFig. 15.36 Normal ocular fundus of the horse 314\u003c\/p\u003e \u003cp\u003eFig. 15.37 Chorioretinitis 315\u003c\/p\u003e \u003cp\u003eFig. 15.38 Retinal detachment 315\u003c\/p\u003e \u003cp\u003eFig. 15.39 Optic disc degeneration 315\u003c\/p\u003e \u003cp\u003eFig. 15.40 Ophthalmic manifestations of proliferative neuropathy 316\u003c\/p\u003e \u003cp\u003eFig. 15.41 Ischemic neuroretinopathy 316\u003c\/p\u003e \u003cp\u003e\u003cb\u003e16 Food and Fiber Animal Ophthalmology 317\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 16.1 Microphthalmia in a goat 318\u003c\/p\u003e \u003cp\u003eFig. 16.2 Strabismus in cattle 318\u003c\/p\u003e \u003cp\u003eFig. 16.3 Orbital neoplasia in cattle 319\u003c\/p\u003e \u003cp\u003eFig. 16.4 Corneoconjunctival dermoid 320\u003c\/p\u003e \u003cp\u003eFig. 16.5 Entropion in sheep 320\u003c\/p\u003e \u003cp\u003eFig. 16.6 Infectious keratoconjunctivitis in a ram 320\u003c\/p\u003e \u003cp\u003eFig. 16.7 Mycoplasmal infectious keratoconjunctivitis in a goat 321\u003c\/p\u003e \u003cp\u003eFig. 16.8 Infectious bovine keratoconjunctivitis 322\u003c\/p\u003e \u003cp\u003eFig. 16.9 Squamous cell carcinoma in cattle 323\u003c\/p\u003e \u003cp\u003eFig. 16.10 Persistent pupillary membranes and pigmented anterior capsular cataract in a cow 325\u003c\/p\u003e \u003cp\u003eFig. 16.11 Albinism and heterochromia iridis 326\u003c\/p\u003e \u003cp\u003eFig. 16.12 Heterochromia iridis in pigs 326\u003c\/p\u003e \u003cp\u003eFig. 16.13 Iridocyclitis in a cow secondary to infectious bovine rhinotracheitis 327\u003c\/p\u003e \u003cp\u003eFig. 16.14 Secondary glaucoma secondary to infectious bovine keratoconjunctivitis 327\u003c\/p\u003e \u003cp\u003eFig. 16.15 Congenital cataract 327\u003c\/p\u003e \u003cp\u003eFig. 16.16 Cataract secondary to anterior uveitis 328\u003c\/p\u003e \u003cp\u003eFig. 16.17 Normal ocular fundus of the cow\/sheep\/goat\/pig 328\u003c\/p\u003e \u003cp\u003eFig. 16.18 Typical or ventral optic nerve head coloboma 330\u003c\/p\u003e \u003cp\u003eFig. 16.19 Ocular fundus inflammation associated with systemic infectious diseases 331\u003c\/p\u003e \u003cp\u003eFig. 16.20 Nutritional retinal degeneration 331\u003c\/p\u003e \u003cp\u003eFig. 16.21 Vitamin A deficiency 332\u003c\/p\u003e \u003cp\u003eFig. 16.22 Normal eye and ophthalmic disease in alpaca and llama 333\u003c\/p\u003e \u003cp\u003e\u003cb\u003e17 Ophthalmology in Exotic Pets 337\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 17.1 Diseases of the snake spectacle 338\u003c\/p\u003e \u003cp\u003eFig. 17.2 Ophthalmic trauma in raptors 339\u003c\/p\u003e \u003cp\u003eFig. 17.3 Exophthalmos in a rabbit 341\u003c\/p\u003e \u003cp\u003eFig. 17.4 Entropion in a rabbit 341\u003c\/p\u003e \u003cp\u003eFig. 17.5 Dacryocystitis and an obstructed nasolacrimal duct in a rabbit 342\u003c\/p\u003e \u003cp\u003eFig. 17.6 Blepharoconjunctivitis in a rabbit 342\u003c\/p\u003e \u003cp\u003eFig. 17.7 \u003ci\u003ePasteurella \u003c\/i\u003econjunctivitis in a rabbit 344\u003c\/p\u003e \u003cp\u003eFig. 17.8 Conjunctival overgrowth in a rabbit 344\u003c\/p\u003e \u003cp\u003eFig. 17.9 Prolapse of the nictitans and its glands in a rabbit 345\u003c\/p\u003e \u003cp\u003eFig. 17.10 Superficial corneal ulcer in a rabbit 346\u003c\/p\u003e \u003cp\u003eFig. 17.11 Anterior uveitis in a rabbit 346\u003c\/p\u003e \u003cp\u003eFig. 17.12 Inherited congenital glaucoma 347\u003c\/p\u003e \u003cp\u003eFig. 17.13 Congenital glaucomas in rabbits 347\u003c\/p\u003e \u003cp\u003eFig. 17.14 Normal rabbit ocular fundus 348\u003c\/p\u003e \u003cp\u003eFig. 17.15 Cataract formation in ferrets 349\u003c\/p\u003e \u003cp\u003eFig. 17.16 Bilateral exophthalmos and elevated nictitans in a ferret 349\u003c\/p\u003e \u003cp\u003e\u003cb\u003e18 Systemic Diseases with Ophthalmic Manifestations 351\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 18.1 Merle ocular dysgenesis 352\u003c\/p\u003e \u003cp\u003eFig. 18.2 Oculoskeletal dysplasia 352\u003c\/p\u003e \u003cp\u003eFig. 18.3 Hydrocephalus 352\u003c\/p\u003e \u003cp\u003eFig. 18.4 Ocular sequelae of canine distemper 353\u003c\/p\u003e \u003cp\u003eFig. 18.5 Ocular signs of infectious canine hepatitis 354\u003c\/p\u003e \u003cp\u003eFig. 18.6 Focal papilloma 354\u003c\/p\u003e \u003cp\u003eFig. 18.7 Hemorrhage caused by Rocky Mountain spotted fever 354\u003c\/p\u003e \u003cp\u003eFig. 18.8 Canine brucellosis 355\u003c\/p\u003e \u003cp\u003eFig. 18.9 Mycotic infections or dermatophytosis affecting the eyelids 356\u003c\/p\u003e \u003cp\u003eFig. 18.10 Blastomycosis 357\u003c\/p\u003e \u003cp\u003eFig. 18.11 Coccidioidomycosis 357\u003c\/p\u003e \u003cp\u003eFig. 18.12 Histoplasmosis 358\u003c\/p\u003e \u003cp\u003eFig. 18.13 Cryptococcosis 358\u003c\/p\u003e \u003cp\u003eFig. 18.14 Ocular aspergillosis 359\u003c\/p\u003e \u003cp\u003eFig. 18.15 Ocular sequelae of toxoplasmosis 359\u003c\/p\u003e \u003cp\u003eFig. 18.16 Ocular sequelae of leishmaniasis 360\u003c\/p\u003e \u003cp\u003eFig. 18.17 Ocular sequelae of protothecosis 361\u003c\/p\u003e \u003cp\u003eFig. 18.18 Intraocular heartworm infestation in the dog 362\u003c\/p\u003e \u003cp\u003eFig. 18.19 Ophthalmomyiasis interna 362\u003c\/p\u003e \u003cp\u003eFig. 18.20 Demodex dermatitis 362\u003c\/p\u003e \u003cp\u003eFig. 18.21 Diabetic cataracts 363\u003c\/p\u003e \u003cp\u003eFig. 18.22 Ocular signs of systemic hypertension 363\u003c\/p\u003e \u003cp\u003eFig. 18.23 Ocular signs of hyperlipidemia 365\u003c\/p\u003e \u003cp\u003eFig. 18.24 Retinal hemorrhage 366\u003c\/p\u003e \u003cp\u003eFig. 18.25 Ocular sequelae of renal failure 366\u003c\/p\u003e \u003cp\u003eFig. 18.26 Uveodermal syndrome 366\u003c\/p\u003e \u003cp\u003eFig. 18.27 Ocular sequelae of uveodermal syndrome 367\u003c\/p\u003e \u003cp\u003eFig. 18.28 Ocular sequelae of lymphoma 367\u003c\/p\u003e \u003cp\u003eFig. 18.29 Ocular sequelae of feline herpesvirus 369\u003c\/p\u003e \u003cp\u003eFig. 18.30 Chlamydophila conjunctivitis 370\u003c\/p\u003e \u003cp\u003eFig. 18.31 Chorioretinitis caused by feline infectious peritonitis 371\u003c\/p\u003e \u003cp\u003eFig. 18.32 Anterior uveitis caused by feline immunodeficiency virus 372\u003c\/p\u003e \u003cp\u003eFig. 18.33 Anterior uveitis in a cat secondary to toxoplasmosis 372\u003c\/p\u003e \u003cp\u003eFig. 18.34 Ocular sequelae of feline leukemia virus 373\u003c\/p\u003e \u003cp\u003eFig. 18.35 Cryptococcosis chorioretinitis 373\u003c\/p\u003e \u003cp\u003eFig. 18.36 Feline panleukopenia 374\u003c\/p\u003e \u003cp\u003eFig. 18.37 Ocular signs of systemic hypertension 375\u003c\/p\u003e \u003cp\u003eFig. 18.38 Ocular anomalies in horses related to coat color 375\u003c\/p\u003e \u003cp\u003eFig. 18.39 Habronemiasis 376\u003c\/p\u003e \u003cp\u003eFig. 18.40 West Nile fever and facial nerve paralysis 377\u003c\/p\u003e \u003cp\u003eFig. 18.41 Conjunctival lymphoma 378\u003c\/p\u003e \u003cp\u003eFig. 18.42 Microphthalmos 378\u003c\/p\u003e \u003cp\u003eFig. 18.43 Ophthalmic anomalies of bovine viral diarrhea 378\u003c\/p\u003e \u003cp\u003eFig. 18.44 Ophthalmic anomalies of systemic infectious bovine rhinotracheitis 379\u003c\/p\u003e \u003cp\u003eFig. 18.45 Secondary chorioretinitis 379\u003c\/p\u003e \u003cp\u003e\u003cb\u003e19 Neuro‐ophthalmic Syndromes 381\u003c\/b\u003e\u003c\/p\u003e \u003cp\u003eFig. 19.1 Horner’s syndrome in the dog\/cat 382\u003c\/p\u003e \u003cp\u003eFig. 19.2 Horner’s syndrome in the horse 383\u003c\/p\u003e \u003cp\u003eFig. 19.3 Facial nerve paralysis and neuroparalytic keratitis 383\u003c\/p\u003e \u003cp\u003eFig. 19.4 Hemifacial spasms 384\u003c\/p\u003e \u003cp\u003eFig. 19.5 Neurotropic keratitis and fifth nerve paralysis 385\u003c\/p\u003e \u003cp\u003eFig. 19.6 Neurogenic keratoconjunctivitis sicca 386\u003c\/p\u003e \u003cp\u003eFig. 19.7 Feline hemidilated pupil 386\u003c\/p\u003e \u003cp\u003eFig. 19.8 Haw’s syndrome 387\u003c\/p\u003e \u003cp\u003eFig. 19.9 Feline strabismus or esotropia 388\u003c\/p\u003e \u003cp\u003eFig. 19.10 Fibrosing strabismus 388\u003c\/p\u003e \u003cp\u003eFig. 19.11 Lateral\/unilateral strabismus 389\u003c\/p\u003e \u003cp\u003eFig. 19.12 Convergence strabismus or esotropia 390\u003c\/p\u003e \u003cp\u003eFig. 19.13 Bovine strabismus 390\u003c\/p\u003e \u003cp\u003eFig. 19.14 Internal ophthalmoplegia or cavernous sinus syndrome 391\u003c\/p\u003e \u003cp\u003eAppendix A: Glossary – Frequently Used Veterinary Ophthalmology Terms 393\u003c\/p\u003e \u003cp\u003eAppendix B: Eye Diseases in the Brachycephalic Breeds 399\u003c\/p\u003e \u003cp\u003eAppendix C: Inherited Cataracts in the Dog, Parts 1 and 2 401\u003c\/p\u003e \u003cp\u003eIndex 403\u003c\/p\u003e \u003cp\u003e\u003cb\u003eKirk N. Gelatt\u003c\/b\u003e, VMD, Diplomate ACVO, is Distinguished Professor Emeritus at the University of Florida in Gainesville, Florida, USA.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eCaryn E. Plummer\u003c\/b\u003e, DVM, Diplomate ACVO, is Associate Professor of Comparative Ophthalmology and Service Chief of the Veterinary Ophthalmology Service at the University of Florida in Gainesville, Florida, USA.\u003c\/p\u003e \u003cp\u003e\u003ci\u003eColor Atlas of Veterinary Ophthalmology, Second Edition \u003c\/i\u003eprovides a compendium of the clinical appearance of ophthalmic diseases likely to be encountered in small, large, or exotic animal practice.  Most diseases are depicted across multiple photographs, showing varying stages and the alterations caused by medical or surgical therapies.  With more than 1,000 images and two new chapters, this Second Edition offers a significant expansion of content and presents a complete resource for veterinary clinical ophthalmology.\u003c\/p\u003e \u003cp\u003eEach chapter covers congenital or developmental disease, inflammatory disorders, traumatic injuries,  degenerative disease, and neoplasia.  For each condition depicted, the text discusses the clinical history, the clinical signs and findings associated with the disease, the rule-outs or differential diagnoses, the recommended treatment, and the prognosis.  \u003ci\u003eColor Atlas of Veterinary Ophthalmology \u003c\/i\u003eis an essential reference for practitioners treating conditions of the animal eye.\u003c\/p\u003e \u003cp\u003e\u003cb\u003eKey features\u003c\/b\u003e\u003c\/p\u003e \u003cul\u003e \u003cli\u003eOffers a pictorial reference to the clinical appearance of diseases and conditions of the animal eye\u003c\/li\u003e \u003cli\u003ePresents multiple presentations of most ophthalmic diseases to show the varying ways the condition might appear\u003c\/li\u003e \u003cli\u003eProvides more than 1,000 high-quality color clinical photographs showing ocular disorders\u003c\/li\u003e \u003cli\u003eIncludes new introductory chapters on ocular anatomy, the ophthalmic exam, and clinical findings in place of the clinical signs chapter\u003c\/li\u003e \u003cli\u003eCovers clinical history, the clinical signs and findings associated with the disease, the rule-outs or differential diagnoses, the recommended treatment, and the prognosis for each disorder\u003c\/li\u003e \u003c\/ul\u003e","brand":"Wiley-Blackwell","offers":[{"title":"Default Title","offer_id":47988947157221,"sku":"NP9781119239444","price":185.95,"currency_code":"USD","in_stock":false}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1842\/7735\/files\/9781119239444.jpg?v=1761782163","url":"https:\/\/k12savings.com\/products\/color-atlas-of-veterinary-ophthalmology-isbn-9781119239444","provider":"K12savings","version":"1.0","type":"link"}